Results 231 to 240 of about 694,744 (291)
Some of the next articles are maybe not open access.

Biomedical and bioethical issues in Parliamentary TA and in Health Technology Assessment

Poiesis & Praxis, 2004
HTA and TA institutions at national parliaments (PTA) both share the same origin and of course have objectives and some of their methods in common. Nevertheless both TA branches developed in some distance during the 1970s and 1980s. Drawing on the case of biomedicine this paper outlines the differences between HTA and PTA, highlighting the “clinical ...
L. Hennen
openaire   +2 more sources

Updating the biomedical engineering curriculum: Inclusion of Health Technology Assessment subjects

2010 Annual International Conference of the IEEE Engineering in Medicine and Biology, 2010
This paper describes the work being carried out at Metropolitan Autonomous University (UAM) in Mexico City with regard to the continuous evaluation and updating of the Biomedical Engineering (BME) curriculum. In particular the courses regarded as part of the BME basic branch are reduced and new sets of elective subjects are proposed in order to bring ...
Fabiola, Martinez Licona   +2 more
openaire   +3 more sources

Biomedical Technology Assessment: The 3Q Method

Biomedical Technology Assessment: The 3Q Method, 2010
Evaluating biomedical technology poses a significant challenge in light of the complexity and rate of introduction in today's healthcare delivery system.
Phillip Weinfurt
openaire   +2 more sources

Biomedical engineering's role in hospital health technology assessment

Proceedings of 17th International Conference of the Engineering in Medicine and Biology Society, 2002
Health technology assessment (HTA) can be defined as research that is intended to help decision makers deal with the development, acquisition, and utilization of healthcare technologies. With restraint, re-engineering and rightsizing now key words in healthcare and government, hospitals are looking for additional value in their healthcare technology ...
S. Elder, N. Corrin
openaire   +2 more sources

Global Survey on Biomedical Engineering Professionals in Health Technology Assessment

2017
One of the projects of the Health Technology Assessment Division of the International Federation for Medical and Biological Engineering is a global survey on biomedical engineering (BME) professionals in health technology assessment (HTA).
M. Medvedec
openaire   +2 more sources

Role of the Biomedical Engineering Department In William Beaumont Hospitalʼs Technology Assessment Process

Journal of Clinical Engineering, 1995
Biomedical/Clinical Engineering Departments with expertise in engineering and technology management have a vital role to play in determining the potential for implementation and cost effectiveness of new medical technologies through technology assessment.
B M, Patail, A N, Aranha
openaire   +3 more sources

Technology assessment in healthcare: A means for pursuing the goals of biomedical engineering

Medical and Biological Engineering and Computing, 1993
The goals of biomedical engineering include the improvement of health and life quality of mankind. However, the contribution of biomedical engineering to those worthy ends must be more clearly related. Biomedical engineers should become more active in demonstrating to policymakers and other parties in healthcare the value of the contributions of ...
exaly   +3 more sources

Innovation strategy management survey of the Chilean biomedical industry. Assessment of windows of opportunities to reduce technological gaps

The International Journal of Health Planning and Management, 2018
SummaryThe convergence of different theories (ie, catch‐up effect and windows of opportunities) allows for the interpretation of different “technological innovation gaps” in Chile's biomedical industry. It is common knowledge that Chile has always had an economy almost exclusively based on services, commodities, and mainly in the exploitation of ...
Tomas Gabriel Bas   +1 more
openaire   +3 more sources

Clinical assessment of biomedical technology

Diseases of the Colon & Rectum, 1993
The rapid expansion of new, unproven, and often expensive biomedical technology requires controlled clinical assessment before widespread diffusion into clinical practice. The accuracy, reliability, and validity all need to be assessed in an unbiased manner to determine whether implementation is of benefit to the clinician and patient.
M J, Solomon, R S, McLeod
openaire   +2 more sources

Home - About - Disclaimer - Privacy